Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY)

Recruiting now · Phase 4

Conditions studied: Decompensated Cirrhosis, Bacterial Infections

In brief

Study to comparing conventrional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.

Key facts

Study ID

NCT05783661

Run by

Eva Bonfill

People needed

198

Starts

2023-12-11

Expected to finish

2027-03-01

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cirrhotic patients with acute decompensation aged ≥18 years.
• Proven or suspected bacterial infection requiring antibiotic therapy (diagnosis will be established according to local guidelines, Appendix 1).
• Signed informed consent or consent given by their legal representatives or close relatives.

You may not qualify if…

• Bacterial infection lasting for > 48 hours.
• Infection in a critically ill cirrhotic patient (ICU admission). In this population, epidemiological surveillance is standard clinical practice.
• MDR colonization or infection in the last month.
• Evidence of current locally advanced or metastatic malignancy (patients with hepatocellular carcinoma within the Milan criteria and non-melanocytic skin cancer can be included).
• Pregnant and/or breast-feeding woman.
• Patients who cannot provide prior informed consent and when there is documented evidence that the patient has no legal surrogate decision-maker and it appears unlikely that the patient will regain consciousness or sufficient ability to provide delayed informed consent.

Where it is running

• Eva Bonfill — Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.